Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02896816 · ClinicalTrials.gov registry record · NA
EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease
A NA study, sponsored by Spaulding Rehabilitation Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02896816: Clinical Trial NA study, sponsored by Spaulding Rehabilitation Hospital.
NCT02896816 is a NA study that was terminated before completion, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02896816, a NA study, was terminated before completion, sponsored by Spaulding Rehabilitation Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Study Purpose: Parkinson's disease leads to severally impaired motor control. The purpose of this study is to better understand and analyze the characteristics of arm muscle activity while doing some reaching tasks and of leg muscles while walking. This will allow the investigators to improve understanding of the mechanisms underlying the motor impairments in Parkinson's disease.
Primary Outcome
Surface EMG upper and lower extremities
Interventions
- OTHER Surface EMG
- OTHER Surface EMG, MRI and PET Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2016-08 |
| Est. Completion | 2021-05-25 |
| Phase | NA |
Why NCT02896816 stopped before completion
NCT02896816 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Surface EMG is the first listed.
NCT02896816 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02896816 about?
NCT02896816 is a clinical study titled "EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease". Study Purpose: Parkinson's disease leads to severally impaired motor control. The purpose of this study is to better understand and analyze the characteristics of arm muscle activity while doing some reaching tasks and of leg muscles while walking. This will allow the investigators to improve under...
What is the current status of trial NCT02896816?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2016-08. Estimated completion is 2021-05-25.
What interventions are being tested in trial NCT02896816?
The interventions under investigation include: Surface EMG (OTHER), Surface EMG, MRI and PET Scan (OTHER).
Who is sponsoring clinical trial NCT02896816?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02896816's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia